Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the 10 best penny stocks that could triple your money. On February 26, Akebia Therapeutics Inc. (NASDAQ:AKBA) outlined its 2026 pipeline expansion and shared expectations for Vafseo data catalysts in the $1 billion dialysis market during its fourth quarter 2025 earnings call. The company reported a total of $227 million in net product revenue for the year, with Vafseo and Auryxia being major contributors. hywards/Shutterstock.com Chief Executive Officer ...

In this article, we will explore 10 penny stocks with potential to rise 1000 percent.Penny stocks can produce eye-catching bursts of upside, but their record against the broader market is usually weaker once you zoom out. Using BlackRock ETF proxies for comparison, the iShares Micro-Cap ETF returned 22.8% in 2025, ahead of the iShares Core S&P 500 ETF’s 17.9%, but over 10 years, the micro-cap fund annualized 9.4% versus 14.8% for the S&P 500 proxy. Risk was also much higher: the micro-cap fund’s three-year ...

In this article, we explore the 10 Popular Penny Stocks on Robinhood to Buy.Robinhood is a FINRA and SEC-regulated broker. It plays the role of a bridge that routes customer orders to market makers and exchanges. The firm was founded to “Democratize finance for all,” and has evolved from a commission-free trading pioneer into what analysts now describe as a diversified financial SuperApp. As of February 2026, the platform had a little over 27 million registered paying users and total platform assets of $314 ...

Core Insights - The article discusses the performance and potential of micro-cap stocks, particularly highlighting the impressive gains of the Russell Microcap index, which surged 74.5% from April 8, 2025, to February 28, 2026, outperforming larger indices like the Russell 1000 and S&P 500, which gained 39.7% and 39.6% respectively [2][3]. Micro-Cap Performance - Micro-caps have shown sustained market leadership due to better relative earnings growth driven by a strong US economy [3]. - The performance of micro and small-caps is also attributed to tougher comparisons for major tech stocks (Mag 7) due to inflated earnings expectations related to AI capital expenditure [3]. Investment Methodology - The article outlines a methodology for selecting penny stocks (priced under $5) that are trading within 0% to 10% of their 52-week highs, focusing on companies with recent noteworthy developments likely to impact investor sentiment [6]. - The selection process emphasizes stocks that are popular among analysts and elite hedge funds, as imitating top hedge fund picks has historically led to market outperformance [7]. Featured Penny Stocks - **Acacia Research Corporation (NASDAQ:ACTG)**: - The company has a price target raised from $5 to $6 by Craig-Hallum, indicating potential undervaluation despite mixed market conditions [8][9]. - Acacia reported a 2.63% year-over-year revenue growth to $50.13 million for fiscal Q4 2025, exceeding expectations by $12.13 million, with an EPS of $0.03 surpassing consensus by $0.17 [10]. - The company is involved in industrial, energy, and technology sectors, with a focus on intellectual property assets [11]. - **Ocugen, Inc. (NASDAQ:OCGN)**: - Initiated with an Outperform rating and a $10 price target, Ocugen is positioned as a leader in gene therapy for blinding ocular disorders, with its lead asset OCU400 in Phase 3 trials for retinitis pigmentosa [12][13]. - The company is developing multiple programs for retinal diseases and expects to file three FDA applications over the next three years [14].

分组1 - The company is profitable with a gross profit margin of 72.6%, which is 250 basis points higher than the previous year, generating an operating profit of $37.3 million for the 12 months ending September 30, 2025 [1] - The company adopted a new organizational structure in May 2025 to accelerate growth and improve financial position, but its stock has declined 35% in 2026 and 59% over the past year [2] - The company generates revenue primarily through fees for its Biote Method tools and sales of proprietary dietary supplements [2][3] 分组2 - KinderCare Learning Companies hit a new 52-week low of $3.20, down 26% in 2026, and has experienced significant declines since its IPO [7][10] - The company has grown its revenue from $1.37 billion in 2021 to $2.69 billion in the 12 months ending September 30, 2025, while transitioning from an operating loss of $93 million to an operating profit of $30.4 million [12] - The return of Tom Wyatt as CEO may provide the necessary change to improve the company's share price, as he is a significant shareholder [14][15] 分组3 - Apartment Investment and Management Co. announced plans to transition from a REIT to complete liquidation of its assets, with expected liquidation distributions between $5.75 and $7.10 per share [16][17] - The company plans to make an initial liquidation distribution of $1.45 per share, with additional distributions expected from property sales [18] - Current share price of $4.24 could yield a return of 34% if distributions are at the high end of projections, with potential annualized returns of 43% if completed by year-end [19]

Market Overview - Investor focus is shifting beyond mega-cap stocks, with earnings revisions improving across various sectors, including small caps, which may unlock value dislocations accumulated over the last three years [1] - For small-cap outperformance to continue, consistent upward earnings revisions and a compression of the valuation spread between small and large caps are necessary [1] Portfolio Positioning - Interest is growing in mid-caps, small-caps, international stocks, and investment-grade fixed income, moving away from a primary focus on US mega-caps [2] - Concerns exist regarding market concentration in mega-cap tech companies and potential disappointments in that sector [2] - The next phase of AI-related trades may involve small and mid-cap companies leveraging AI products for productivity gains, as these firms are more labor-intensive and may have greater earnings leverage if AI enhances productivity [2] Citius Oncology Inc. (NASDAQ:CTOR) - Citius Oncology has entered an exclusive distribution agreement with Uniphar to expand its oncology treatment, LYMPHIR, in Europe, marking its third major international agreement [7] - LYMPHIR is currently FDA-approved in the US but lacks commercial marketing authorization in Europe, limiting its availability to specific patient groups under local legal frameworks [8] - The drug targets patients with Stage I-III cutaneous T-cell lymphoma, functioning as a recombinant fusion protein to selectively destroy cancerous T-cells [9][10] Ceragon Networks Ltd. (NASDAQ:CRNT) - Ceragon Networks reported Q4 2025 revenue of $82.3 million, a 23% decline from Q4 2024, with full-year revenue totaling $338.7 million, down 14.1% year-over-year [11] - Management is optimistic for 2026, projecting revenue guidance of $355 to $385 million, driven by the launch of new products and a multimillion-dollar private network contract in the Asia-Pacific region [12] - The company is diversifying revenue streams through private networks in mining and energy sectors while managing supply chain costs by qualifying secondary sources [13][14]

Core Viewpoint - The article discusses the increasing interest in small and micro-cap stocks, particularly penny stocks, as investors seek opportunities amid concerns of a market correction, with Goldman Sachs highlighting its top 12 penny stock picks [1][4]. Market Performance - The S&P SmallCap 600 index has risen over 6% this year, while the iShares Micro Cap ETF is up about 8%. In contrast, the S&P 500 has only increased by 0.35% during the same period, indicating a shift in investor focus towards undervalued small-cap stocks [2]. - Small stocks have underperformed compared to large stocks in recent years, but there is an expectation of earnings growth that could lead to a rotation towards small-cap stocks [3]. Economic Outlook - Goldman Sachs maintains a positive macro outlook for small-cap stocks, predicting that the economic environment will support their performance through 2026. The expectation of interest rate cuts is seen as beneficial for penny and small-cap stocks [4][5]. - The firm believes that the markets are not fully accounting for the potential strength of the US economy in the coming year, which typically favors small-cap stocks during cyclical rallies [5]. Investment Strategy - Goldman Sachs' methodology for selecting its top penny stock picks involves analyzing equity holdings, focusing on companies trading under $5 per share, and considering their popularity among hedge funds [7]. - The strategy of imitating top hedge fund stock picks has historically outperformed the market, with a reported return of 427.7% since May 2014 [9]. Company Highlights - **Grupo Televisa, S.A.B. (NYSE:TV)**: Goldman Sachs holds an equity stake of $902,471, with a share price of $3.32. The company is expected to release its fourth-quarter results soon, with optimistic projections for 2026 due to favorable economic conditions in Mexico [10][11][12]. - **AtaiBeckley Inc. (NASDAQ:ATAI)**: Goldman Sachs has a stake of $2.38 million in AtaiBeckley, which is focused on developing treatments for mental health disorders. The company has shown promising clinical data for its drug BPL-003, which has received Breakthrough Therapy designation from the FDA [16][17][19][20].

Industry Overview - Small-cap and penny stocks are experiencing a notable rally, with the Russell 2000 index up by over 5%, significantly outperforming the S&P 500, which is up by only 1.7% [1] - The rally is driven by expectations of market-beating results from these companies, which are trading at discounted valuations [1][2] - The Federal Reserve's anticipated monetary policy easing is further supporting the case for investing in penny and small-cap stocks [2] January Effect - The January effect is benefiting small-cap companies as investors are buying smaller stocks, particularly those that faced tax-loss selling in the previous quarter [3] - The Russell 2000 index has shown strong performance in January, suggesting potential continued strength into February [3] Fundamentals and Valuations - Fundamentals for small-cap companies are improving, with their 1-year price-to-earnings multiples being 30% lower than those of large-cap companies [4] - Small caps have shown earnings growth that slightly exceeded larger companies for the first time in thirteen quarters [4] Seasonal Trends - Historically, small caps perform better in midterm election years, averaging a 1.3% advance in February compared to the S&P 500's average of 0.3% [5] - Current seasonal patterns indicate a hawkish bias towards interest rates, favoring small-cap stocks [5] Investment Opportunities - The S&P SmallCap 600 index is already up by more than 5% for the year, indicating a favorable environment for investing in penny stocks trading under $5 [6] - A list of 14 NYSE penny stocks has been compiled based on popularity among hedge funds and potential upside of over 30% [8][9] Company Highlights - **Nouveau Monde Graphite Inc. (NYSE:NMG)**: Current share price is $2.09 with an upside potential of 107.33%. The company has a net asset value of $919 million or $3.51 per share, factoring in a cash balance of $68.8 million and debt of $11.6 million [11][12]. It has signed a 7-year off-take agreement with the Canadian government for 30,000 tons per annum of graphite concentrate [13][14]. - **Auna SA (NYSE:AUNA)**: Current share price is $4.76 with an upside potential of 53.36%. Analysts expect significant growth due to a $500 million expansion in Mexico and a strategic partnership with Sojitz [15][16][17]. The company operates a vertically integrated network of healthcare facilities in Latin America, focusing on high-complexity care [18].

Company Overview - FuboTV is a streaming platform primarily focused on sports, often compared to Netflix, but it is not the largest player in the sports niche [3] - The company recently merged with Hulu+ Live TV, owned by Disney, which closed in October [3][4] Merger Impact - The merger allows FuboTV to diversify its offerings beyond sports, as Hulu+ Live TV has a larger and varied content library [4] - FuboTV's subscriber base has significantly increased to almost 6 million in North America, surpassing its previous total [5] - Disney now holds a 70% stake in the new FuboTV, providing substantial backing and expertise to navigate the competitive landscape [5][6] Competitive Landscape - Despite the merger, FuboTV faces challenges in growing its paid membership, with only a 1.1% increase in subscribers year-over-year before the merger [7] - The company also experienced a decline in its rest-of-world category, with a 9.5% drop in members [7] - Competition in the sports streaming niche is intensifying, with major players like Netflix entering the live sports market [8] Future Prospects - FuboTV could improve its performance by offering bundled services at attractive prices and expanding into new territories with Disney's support [10] - The streaming market is expected to continue growing, potentially allowing FuboTV to capture market share from traditional cable [10]

分组1 - The article discusses fundamentally strong penny stocks that analysts recommend for investment, highlighting their potential despite the general volatility associated with such stocks [1] - The broader economic sentiment is shifting towards optimism, with executives reporting the brightest near-term expectations seen this year, driven by a focus on customer needs and technology investments [2][3] - A recent McKinsey Global Survey indicates that 63% of executives expect their companies' profits to increase in the next six months, the highest share since December 2024 [4] 分组2 - The methodology for selecting penny stocks involved filtering for stocks trading under $5, with market capitalizations over $2 billion and an upside potential of at least 20% [6] - The article emphasizes the importance of hedge fund holdings, suggesting that imitating top stock picks from hedge funds can lead to market outperformance [7] - The quarterly newsletter strategy has achieved a return of 427.7% since May 2014, significantly outperforming its benchmark [8] 分组3 - Clarivate Plc (NYSE:CLVT) has an upside potential of 20.34% as of December 19, 2025, with a market capitalization of $2.27 billion and 25 hedge fund holders [9] - Morgan Stanley downgraded Clarivate to Underweight, citing struggles in its turnaround and limited growth potential due to funding pressures and competition [9][11] - Analyst sentiment on Clarivate is mixed, with 30% of analysts rating it as a Buy and a wide range in consensus price targets, indicating uncertainty [13] 分组4 - Coty Inc. (NYSE:COTY) has an upside potential of 22.70% as of December 19, 2025, with a market capitalization of $2.84 billion and 30 hedge fund holders [15] - Coty sold its remaining 25.8% stake in Wella for $750 million, intending to use the proceeds to pay off debt amid challenges in the mass beauty segment [15][16] - Citi has reduced Coty's price target to $3.50 from $4.25, maintaining a Neutral rating, reflecting a revised outlook for the beauty sector [18]